WILLARD M. WELCH

Person

MYSTIC, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
NK1 antagonists
- Patent number 7,241,798
- Issue date Jul 10, 2007
- Pfizer Inc.
- Barbara E. Segelstein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sertraline oral concentrate
- Patent number 7,067,555
- Issue date Jun 27, 2006
- Pfizer Inc.
- Nancy J. Harper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity
- Patent number 7,009,051
- Issue date Mar 7, 2006
- Pfizer Inc.
- Willard M. Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thieno-pyrimidin-4-one AMPA antagonists
- Patent number 6,921,764
- Issue date Jul 26, 2005
- Pfizer Inc.
- Bertrand L Chenard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-HT receptor ligands and uses thereof
- Patent number 6,825,198
- Issue date Nov 30, 2004
- Pfizer Inc.
- Phoebe Chiang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sertraline oral concentrate
- Patent number 6,727,283
- Issue date Apr 27, 2004
- Pfizer Inc.
- Nancy J. Harper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazolin-4-one AMPA antagonists
- Patent number 6,627,755
- Issue date Sep 30, 2003
- Pfizer Inc.
- Bertrand L. Chenard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
- Patent number 6,448,265
- Issue date Sep 10, 2002
- Pfizer, Inc.
- William Stephen Faraci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
- Patent number 6,441,018
- Issue date Aug 27, 2002
- Pfizer Inc.
- William Stephen Faraci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment...
- Patent number 6,380,204
- Issue date Apr 30, 2002
- Pfizer Inc.
- Bertrand Leo Chenard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-...
- Patent number 6,323,208
- Issue date Nov 27, 2001
- Pfizer Inc.
- Bertrand L. Chenard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-r...
- Patent number 6,306,864
- Issue date Oct 23, 2001
- Pfizer Inc.
- Willard McKowan Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,3 disubstituded-4(3H)-quinazolinones
- Patent number 6,303,615
- Issue date Oct 16, 2001
- Pfizer Inc.
- Mark L. Elliott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
- Patent number 6,255,322
- Issue date Jul 3, 2001
- Pfizer Inc.
- Willard McKowan Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of administering CRF antagonists
- Patent number 6,200,979
- Issue date Mar 13, 2001
- Gene M. Bright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering AMPA receptor antagonists to treat dyskine...
- Patent number 6,136,812
- Issue date Oct 24, 2000
- Pfizer Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
- Patent number 6,103,900
- Issue date Aug 15, 2000
- Pfizer Inc.
- William Stephen Faraci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline-4-one AMPA antagonists
- Patent number 6,060,479
- Issue date May 9, 2000
- Pfizer Inc.
- Bertrand L. Chenard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
- Patent number 6,005,109
- Issue date Dec 21, 1999
- Pflizer Inc.
- William Stephen Faraci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazoles as corticotropin-releasing factor (CRF) antag...
- Patent number 5,968,944
- Issue date Oct 19, 1999
- Pfizer Inc.
- Gene M. Bright
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
- Patent number 5,962,457
- Issue date Oct 5, 1999
- Pfizer Inc.
- Bertrand L. Chenard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazoles as CRF antagonists
- Patent number 5,958,948
- Issue date Sep 28, 1999
- Pfizer, Inc.
- Gene M. Bright
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
- Patent number 5,712,303
- Issue date Jan 27, 1998
- Pfizer Inc.
- William Stephen Faraci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazoles as CRF antagonists
- Patent number 5,705,646
- Issue date Jan 6, 1998
- Pfizer Inc.
- Gene M. Bright
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of administering CRF antagonists
- Patent number 5,646,152
- Issue date Jul 8, 1997
- Pfizer Inc.
- Gene M. Bright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing sertraline intermediates
- Patent number 5,442,116
- Issue date Aug 15, 1995
- Pfizer Inc.
- Willard M. Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Certain 5-aryl-2-[(4-aryl)-4-hydroxybutyn-2-yl]-1,2,3,4-.gamma.-car...
- Patent number 4,568,749
- Issue date Feb 4, 1986
- Pfizer Inc.
- Willard M. Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-n...
- Patent number 4,556,676
- Issue date Dec 3, 1985
- Pfizer Inc.
- Willard M. Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-nap...
- Patent number 4,536,518
- Issue date Aug 20, 1985
- Pfizer Inc.
- Willard M. Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing carboline derivatives
- Patent number 4,510,308
- Issue date Apr 9, 1985
- Pfizer Inc.
- Willard M. Welch
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NK1 antagonists
- Publication number 20050272800
- Publication date Dec 8, 2005
- Pfizer Inc.
- Barbara E. Segelstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NK1 and NK3 antagonists
- Publication number 20050256164
- Publication date Nov 17, 2005
- Pfizer Inc.
- Brian T. O'Neill
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-HT receptor ligands and uses thereof
- Publication number 20050090503
- Publication date Apr 28, 2005
- Pfizer Inc.
- Phoebe Chiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-HT receptor ligands and uses thereof
- Publication number 20050054656
- Publication date Mar 10, 2005
- Pfizer Inc.
- Phoebe Chiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NK1 antagonist
- Publication number 20050043354
- Publication date Feb 24, 2005
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-HT receptor ligands and uses thereof
- Publication number 20050032809
- Publication date Feb 10, 2005
- Pfizer Inc.
- Phoebe Chiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-HT receptor ligands and uses thereof
- Publication number 20050020604
- Publication date Jan 27, 2005
- Pfizer Inc.
- Phoebe Chiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sertraline oral concentrate
- Publication number 20040161434
- Publication date Aug 19, 2004
- Pfizer Inc.
- Nancy J. Harper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quinazolin-4-one ampa antagonists
- Publication number 20040049039
- Publication date Mar 11, 2004
- Pfizer Inc.
- Bertrand L. Chenard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(2-Pyridyl)piperazines having 5HT7 receptor agonist activity
- Publication number 20040014769
- Publication date Jan 22, 2004
- Pfizer Inc.
- Willard M Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-HT receptor ligands and uses thereof
- Publication number 20030125334
- Publication date Jul 3, 2003
- Phoebe Chiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-HT receptor ligands and uses thereof
- Publication number 20030105106
- Publication date Jun 5, 2003
- Phoebe Chiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SERTRALINE ORAL CONCENTRATE
- Publication number 20030096868
- Publication date May 22, 2003
- NANCY J. HARPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
- Publication number 20030008880
- Publication date Jan 9, 2003
- Pfizer Inc.
- Willard M Welch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONISTIC ACTIVITY
- Publication number 20020049227
- Publication date Apr 25, 2002
- WILLIAM STEPHAN FARACI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONISTIC ACTIVITY
- Publication number 20020016333
- Publication date Feb 7, 2002
- WILLIAM STEPHEN FARACI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination of growth hormone secretagogues and antidepressants
- Publication number 20020002137
- Publication date Jan 3, 2002
- Frank Robert Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF ADMINSTERING AN AMPA RECEPTOR ANTAGONIST TO TREAT DYSKIN...
- Publication number 20010034345
- Publication date Oct 25, 2001
- J.TIMOTHY GREENAMYRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

WILLARD M. WELCH

Person

Patents Grantslast 30 patents

NK1 antagonists

Sertraline oral concentrate

4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity

Thieno-pyrimidin-4-one AMPA antagonists

5-HT receptor ligands and uses thereof

Sertraline oral concentrate

Quinazolin-4-one AMPA antagonists

Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity

Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity

Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment...

Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-...

Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-r...

2,3 disubstituded-4(3H)-quinazolinones

2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Methods of administering CRF antagonists

Methods of administering AMPA receptor antagonists to treat dyskine...

Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity

Quinazoline-4-one AMPA antagonists

Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity

Substituted pyrazoles as corticotropin-releasing factor (CRF) antag...

2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones

Substituted pyrazoles as CRF antagonists

Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity

Substituted pyrazoles as CRF antagonists

Methods of administering CRF antagonists

Process for preparing sertraline intermediates

Certain 5-aryl-2-[(4-aryl)-4-hydroxybutyn-2-yl]-1,2,3,4-.gamma.-car...

Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-n...

Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-nap...

Process for preparing carboline derivatives

Patents Applicationslast 30 patents

NK1 antagonists

NK1 and NK3 antagonists

5-HT receptor ligands and uses thereof

5-HT receptor ligands and uses thereof

NK1 antagonist

5-HT receptor ligands and uses thereof

5-HT receptor ligands and uses thereof

Sertraline oral concentrate

Quinazolin-4-one ampa antagonists

4-(2-Pyridyl)piperazines having 5HT7 receptor agonist activity

5-HT receptor ligands and uses thereof

5-HT receptor ligands and uses thereof

SERTRALINE ORAL CONCENTRATE

4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity

PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONISTIC ACTIVITY

PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONISTIC ACTIVITY

Combination of growth hormone secretagogues and antidepressants

METHODS OF ADMINSTERING AN AMPA RECEPTOR ANTAGONIST TO TREAT DYSKIN...